External Source
Checkmate 238: 9-year Outcomes Of Adjuvant Nivolumab Vs Ipilimumab In Melanoma
Synopsis
Paolo Ascierto, MD, Istituto Tumori Fondazione Pascale, Naples, Italy, comments on the final nine-year results from the Phase III ...
You Might Also Like
Download Options
Choose a download method below. All links open in new tabs.
| Service | Features | Action |
|---|---|---|
| SaveFrom |
MP4 & MP3 • HD Quality • Browser Extension Available
|
Download |
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.